In a random sample from the TNT ( Treating to New Targets ) trial , OxPL-apoB levels were measured in 1,503 patients at randomization ( after an 8-week run-in period taking atorvastatin 10 mg ) and 1 year after being randomized to atorvastatin 10 or 80 mg .